Skip to content

Management of Childhood Pancytopenia

Management of Childhood Pancytopenia in Heamatology Unit in Assiut University Hospital

Status
UNKNOWN
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT03521947
Enrollment
25
Registered
2018-05-11
Start date
2018-06-01
Completion date
2019-12-01
Last updated
2018-05-11

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Pancytopenia

Keywords

MCP

Brief summary

Pancytopenia is an important hematologic Problem.it is a decrease in all three cellular elements of peripheral blood leading to aneamia, leucopenia and thrombocytopenia.

Detailed description

Pancytopenia usually presents with symptoms of bone marrow failure such as pallor, dysnea, brusing and increased tendency to infections. The incidence of various disorders causing pancytopenia varies according to Geographical distribution and genetic mutations. It can result from : * Failure of production of hematopoietic progenitors in bone marrow as in aplastic aneamia. * Bone marrow infiltration by malignant cells as in acute leukemia. * Antibodies mediated bone marrow suppression as in systemic lupus. * Ineffective hematopoiesis and dysplasia as in nutrition deficiency. * Peripheral sequestration of blood cells in over active reticuloendothelial system as in hypersplenism. Pancytopenia is not a disease entity but a triad of findings that may result from primary or secondary bone marrow involvement. Bone marrow aspiration and biopsy evaluation along with clinical correlation are important to evaluate the causes of pancytopenia and plan further investigations and treatment. Pancytopenia can result from damage to bone marrow evidanced by low reticulocyte count, or increased destruction of the peripheral blood with increased reticulocyte count. Bone marrow examination is a simple and safe invasive procedure for evaluating the causes of pancytopenia. The hypoplastic marrow which occurs in 2% of pediatrics acute lymphoblastic leukemia may be misdiagnosed as aplastic aneamia. Studies done have shown leukemia to be the second most common cause of pancytopenia in pediatrics, marginally behind aplastic aneamia.

Interventions

DIAGNOSTIC_TESTComplete blood picture

Iaboratory investigation

Sponsors

Assiut University
Lead SponsorOTHER

Study design

Observational model
CASE_ONLY
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
4 Weeks to 18 Years

Inclusion criteria

* All childrens and adolescents suffering from pancytopenia attending heamatology unit of pediatric department Assiut University Hospital will be included.

Exclusion criteria

* childrens and adolescents suffering from pancytopenia due to malignancy.

Design outcomes

Primary

MeasureTime frameDescription
AvailabilityOne yearBone marrow examination for all cases \[evaluate the causes of pancytopenia and plan further investigations and treatment.\]

Secondary

MeasureTime frameDescription
ModificationOne yearGuidelines for management of pancytopenia modified or not? \[Strategy of blood elements transfusion in treatment\]

Contacts

Primary ContactAhmed Gadelrab Askr, Professor
ahmed.mohamed35@med.au.edu.eg01114064050

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026